AU Patent
AU2001229491A1 — Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
Assigned to Merck and Co Inc · Expires 2001-07-31 · 25y expired
What this patent protects
Patent listed against Trulance.
Drugs covered by this patent
- Trulance (PLECANATIDE) · Salix
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.